# OnCo record tar-210 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/tar-210/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "tar-210" ;
  schema:name "TAR-210"@en ;
  schema:description "TAR-210 is an experimental small molecule (intravesical drug-releasing system) from Janssen Research & Development in phase 3 trials for bladder & urothelial cancer, aimed at FGFR2."@en ;
  schema:url <https://onco.cc/drugs/tar-210/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=JNJ-42756493> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "small molecule (intravesical drug-releasing system)" ;
  onco:cancers <https://onco.cc/cancers/urothelial/> ;
  onco:targets <https://onco.cc/targets/fgfr2/> ;
  onco:companies <https://onco.cc/companies/johnson-johnson/> ;
  onco:trials <https://onco.cc/trials/nct06919965/>, <https://onco.cc/trials/nct06319820/> .